Jeffrey McGroarty
Jeffrey McGroarty
Chief Financial Officer
Annovis Bio, Inc.
Jeff is a financial executive with experience in investor relations, working with analysts, creditors and financial institutions, planning and analysis, IPOs, capital allocation, SEC communications and reporting, accounting, acquisitions and turnarounds. He is currently the CFO of Annovis Bio, Inc., a clinical stage biotech developing drugs for the treatment of Alzheimer's and Parkinson's diseases and was previously CFO of Safeguard Scientifics.